✦ LIBER ✦

Immunomodulatory drug FTY720 induces regulatory CD4+CD25+ T cells in vitro

✍ Scribed by P. J. Zhou; H. Wang; G. H. Shi; X. H. Wang; Z. J. Shen; D. Xu

Book ID: 108701040
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 288 KB
Volume: 157
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.2009.03942.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro generation of CD4+CD25+ regulat

In vitro generation of CD4+CD25+ regulatory cells from murine naive T cells

✍ Fantini, Massimo C; Dominitzki, Sabine; Rizzo, Angelo; Neurath, Markus F; Becker 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 276 KB

CD4+CD25+ T cells as immunoregulatory T

CD4+CD25+ T cells as immunoregulatory T cells in vitro

✍ Jian-Guo Chai; Julia Y. S. Tsang; Robert Lechler; Elizabeth Simpson; Julian Dyso 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

We have further characterized the in vitro phenotype and function of anergic and suppressive CD4(+)25(+) T cells. Following TCR ligation, DO.11.10 CD4(+)25(+) T cells suppress the activation of OT-1 CD8(+)25(-) T cells in an antigen nonspecific manner. Although suppression was seen when using a mixt

Infliximab therapy induces increased pol

Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis

✍ L. Diluvio; M.L. Romiti; F. Angelini; E. Campione; P. Rossi; J.C. Prinz; S. Chim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

CD4+CD25+regulatory T cells in human lup

CD4+CD25+regulatory T cells in human lupus erythematosus

✍ Annegret Kuhn; Stefan Beissert; Peter H. Krammer 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

CD4+CD25+ REGULATORY T CELLS IN HEALTH A

CD4+CD25+ REGULATORY T CELLS IN HEALTH AND DISEASE

✍ Haiying Liu; Bernard P Leung 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

IL-2 induces in vivo suppression by CD4+

IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells

✍ Susan Brandenburg; Takeshi Takahashi; Maurus de la Rosa; Marko Janke; Gabriele K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

## Abstract Interleukin‐2 (IL‐2) treatment is currently used to enhance T cell‐mediated immune responses against tumors or in viral infections. At the same time, IL‐2 is essential for the peripheral homeostasis of CD4^+^CD25^+^Foxp3^+^ regulatory T cells (Treg). In our study, we show that IL‐2 is a